Industry News
Cancer Therapeutics licences breast cancer programs
Two FAK inhibitors developed by Australia's Cancer Therapeutics CRC – which are showing promise in treating triple-negative breast cancers and other solid tumours – are on their way to commercialisation. [ + ]
Novel nanostructures to realise hydrogen’s energy potential
For the first time, engineers at the University of New South Wales have demonstrated that hydrogen can be released and reabsorbed from a promising storage material, overcoming a major hurdle to its use as an alternative fuel source. [ + ]
Immuron testing anti-influenza drug against swine flu
Immuron (ASX:IMC) has started a new round of animal studies for its IMM-255 OTC influenza treatment candidate, this time in the swine flu strain. [ + ]
AtCor wins $1.1m deal for SphygmoCor XCEL
AtCor Medical (ASX:ACG) has secured a $1.1 million contract to provide its SphygmoCor XCEL cardiac monitoring system to an international pharmaceutical company. [ + ]
Thermo Fisher Scientific forms Technology Alliance Partnership with Princeton scientists
Thermo Fisher Scientific has entered into a Technology Alliance Partnership agreement with scientists at Princeton University, establishing a formal collaboration to accelerate research in triple quadrupole and high-resolution accurate mass (HRAM) liquid chromatography-mass spectrometry (LCMS) for life science applications. [ + ]
Scientists can now block heroin, morphine addiction
In a major breakthrough, an international team of scientists has proved that addiction to morphine and heroin can be blocked, while at the same time increasing pain relief. [ + ]
Bioniche to sell equine probiotic
Bioniche (ASX:BNC) is continuing to build up its animal health product portfolio, signing a deal to allow it to distribute an equine probiotic. [ + ]
AusBiotech comments on the National Research Investment Plan discussion paper
AusBiotech has made a formal response to the Federal Government’s discussion paper on the National Research Investment Plan (NRIP) giving the Australian Research Committee (ARCom) a biotechnology industry perspective. [ + ]
Major breakthrough in hepatitis C vaccine development
Researchers at the Burnet Institute have solved a hepatitis C vaccine mystery which, once developed, could be the first ever preventative vaccine for the virus. [ + ]
Doors open for new medical research
Lifesaving medical research received a major boost yesterday, with the opening of the final stage of The John Curtin School of Medical Research (JCSMR) at The Australian National University. [ + ]
Olympic lab leaves life sciences legacy
The London 2012 anti-doping facilities, operated by King’s College London, will be developed after the Olympic and Paralympic Games into a world-class resource that could help revolutionise healthcare. [ + ]
Feature: Born or made?
What makes a champion? With Olympic fever running hot, this is a question that is likely to have been asked more than a few times in recent weeks both in living rooms and locker rooms worldwide. [ + ]
UNCOVER: unlocking Australia’s hidden mineral wealth
The Australian Academy of Science has welcomed the launch of UNCOVER: Searching the deep earth, a visionary new project to unlock Australia’s enormous potential mineral wealth. [ + ]
Busselton people help type 2 diabetes world research
Busselton residents and researchers from The University of Western Australia have contributed to a worldwide scientific collaboration that has identified new genetic links in the quest to map the biological pathways that cause diabetes. [ + ]
Stronger patents help protect innovative Australian exporters
Innovative Australian exporters will have a better chance of protecting their technology overseas following the recent approval of stronger patent standards. [ + ]